Clinical Trial

Thermoacoustic Method for Estimating Liver Fat Fraction

Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this study is to use our Thermoacoustic Enhanced Ultrasound device to measure the fat levels in your liver and compare it to the the gold standard MRI PDFF measurements. Participants will have a scan with our device, then they will go have an abdominal MRI completed. The goal is to create a more accessible device to measure liver fat as it is an indicator for overall health and metabolic diseases.
Trial Details
NCT Number NCT07321925
Lead Sponsor Endra Lifesciences
Conditions MASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated Steatohepatitis), Fatty Liver Disease, Nonalcoholic
Enrollment 49 participants
Start Date 2025-08-15
Primary Completion 2025-10-30 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-01-07